All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • MR001Phase 21 trial

    Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)

  • MRG007Phase 21 trial

    Lepu Biopharma Co., Ltd. · Advanced Colorectal Cancer

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • MVA-209-FSPPhase 21 trial

    Nouscom SRL · Solid Tumor, Adult

  • N17350Phase 21 trial

    Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin

  • Nab-placlitaxelPhase 21 trial

    BioNTech SE · Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers

  • NadunolimabCAN04Phase 21 trial

    Cantargia AB · Triple Negative Breast Cancer

  • narmafotinibPhase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer Metastatic

  • NazartinibEGF816Phase 21 trial

    Novartis · Advanced Solid Tumors Which Are cMET-dependent

  • NBQ72SQBS10072SPhase 21 trial

    Nantong Bencao Quadriga Medical Technology Co. Ltd. · Breast Cancer

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NDI-219216Phase 21 trial

    Nimbus Wadjet, Inc. · Advanced Solid Tumors Cancer, MSI-H Cancer

  • NemvaleukinALKS 4230Phase 21 trial

    Mural Oncology, Inc · Advanced Solid Tumor

  • NEO-201Phase 21 trial

    Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer

  • NEO212POH-TMZPhase 21 trial

    Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

  • NG101mPhase 21 trial

    NeuGATE Theranostics · Glioblastoma Multiforme

  • NGM120Phase 21 trial

    NGM Biopharmaceuticals, Inc · Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia

  • NHT102Phase 21 trial

    Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)

  • NKT2152Phase 21 trial

    Roche (Genentech) · Advanced Liver Cancers

  • NKTR-255Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • NP137Phase 21 trial

    NETRIS Pharma · Endometrial Carcinoma, Cervix Carcinoma

  • NRC-2694-APhase 21 trial

    NATCO Pharma Ltd. · Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

  • NTS071Phase 21 trial

    Nutshell Therapeutics (Shanghai) Co., LTD. · Advanced Solid Tumors

  • NUV-1511Phase 21 trial

    Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • OBI-902Phase 21 trial

    OBI Pharma, Inc · Advanced Solid Tumor

  • OBI-992Phase 21 trial

    OBI Pharma, Inc · Advanced Solid Tumor

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • ODM-216Phase 21 trial

    Orion Corporation, Orion Pharma · Advanced Solid Tumors Cancer

  • OKI-179Phase 21 trial

    OnKure, Inc. · RAS Mutation, NRAS Gene Mutation, Melanoma

  • ONO-4538HSCPhase 21 trial

    Ono Pharmaceutical Co., Ltd. · Pediatric Malignant Solid Tumor and Epithelioid Sarcoma

  • ONO-7703Phase 21 trial

    Ono Pharmaceutical Co., Ltd. · Pan-tumor

  • OPM-101Phase 21 trial

    Oncodesign Precision Medicine · Advanced Melanoma

  • OR502Phase 21 trial

    OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm

  • ORIC-114Phase 21 trial

    ORIC Pharmaceuticals · Solid Tumors

  • OSE-279Phase 21 trial

    OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)

  • OST31-164Phase 21 trial

    Emerald Clinical Inc. · Bone Cancer

  • OTP-01Phase 21 trial

    Ottimo Pharma Limited · Advanced Solid Tumors

  • PBP1510Phase 21 trial

    Prestige Biopharma Limited · Pancreatic Cancer

  • PE0105Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors

  • PE0116Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors

  • PEGPH20Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • PempulimabPhase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Nasopharyngeal Carcinoma

  • PepinemabPhase 21 trial

    Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma

  • PF-0704091Phase 21 trial

    Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

  • Genelux Corporation · Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer

  • PlixorafenibFORE8394, PLX-8394Phase 21 trial

    Fore Biotherapeutics · Cancer Harboring BRAF Alterations, HGG, LGG

  • PM1009Phase 21 trial

    Biotheus Inc. · HCC, Liver Cancer

  • PMD-026Phase 21 trial

    Phoenix Molecular Designs · Metastatic Breast Cancer

  • TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)

  • PRGN-2009Phase 21 trial

    Precigen, Inc · Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy

NewerPage 22 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.